What is the current valuation of the Germany Allergy Immunotherapy Market?

As of 2024, the market valuation was 277.34 USD Million. Read More

What is the projected market size for the Germany Allergy Immunotherapy Market by 2035?

The market is projected to reach 747.45 USD Million by 2035. Read More

What is the expected CAGR for the Germany Allergy Immunotherapy Market during the forecast period 2025 - 2035?

The expected CAGR for the market during this period is 9.43%. Read More

Which segments are included in the Germany Allergy Immunotherapy Market by indication?

The market segments by indication include Allergic Rhinitis, Allergic Asthma, Atopic Dermatitis, and Food Allergies. Read More

What were the market values for Allergic Rhinitis and Allergic Asthma in 2024?

In 2024, the market values were 111.0 USD Million for Allergic Rhinitis and 70.0 USD Million for Allergic Asthma. Read More

How does the market for Intranasal Immunotherapy compare to other types in 2024?

In 2024, Intranasal Immunotherapy had a market value of 117.34 USD Million, indicating strong performance compared to other types. Read More

What are the key players in the Germany Allergy Immunotherapy Market?

Key players include Allergopharma, Boehringer Ingelheim, Merck KGaA, and ALK-Abello, among others. Read More

What is the market segmentation by administration route in the Germany Allergy Immunotherapy Market?

The market is segmented by administration route into Injection, Sublingual, Oral, and Intranasal. Read More

What were the market values for Pediatric and Adult demographics in 2024?

In 2024, the market values were 50.0 USD Million for Pediatric and 150.0 USD Million for Adult demographics. Read More

What is the future outlook for the Germany Allergy Immunotherapy Market?

The market is expected to grow significantly, reaching 747.45 USD Million by 2035, driven by increasing demand and innovation. Read More

Germany Allergy Immunotherapy Market

ID: MRFR/HC/54527-HCR

200 Pages

Nidhi Mandole

Last Updated: May 12, 2026

Germany Allergy Immunotherapy Market Research Report: By Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy, Oral Immunotherapy), By Product (Allergen Extracts, Conventional Immunotherapy, Biologics), By Indication (Allergic Rhinitis, Allergic Asthma, Atopic Dermatitis, Food Allergies) andBy Patient Type (Pediatric, Adult, Geriatric)- Forecast to 2035

Germany Allergy Immunotherapy Market Infographic

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Germany Allergy Immunotherapy Market, BY Indication (USD Million) | |
  1. 4.1.1 Allergic Rhinitis | |
  2. 4.1.2 Allergic Asthma | |
  3. 4.1.3 Atopic Dermatitis | |
  4. 4.1.4 Food Allergies |
2. 4.2 Germany Allergy Immunotherapy Market, BY Type of Immunotherapy (USD Million) | |
  1. 4.2.1 Subcutaneous Immunotherapy | |
  2. 4.2.2 Sublingual Immunotherapy | |
  3. 4.2.3 Oral Immunotherapy | |
  4. 4.2.4 Intranasal Immunotherapy |
3. 4.3 Germany Allergy Immunotherapy Market, BY Administration Route (USD Million) | |
  1. 4.3.1 Injection | |
  2. 4.3.2 Sublingual | |
  3. 4.3.3 Oral | |
  4. 4.3.4 Intranasal |
4. 4.4 Germany Allergy Immunotherapy Market, BY Patient Demographics (USD Million) | |
  1. 4.4.1 Pediatric | |
  2. 4.4.2 Adult | |
  3. 4.4.3 Geriatric | |
  4. 4.4.4 Gender Specific 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Germany Allergy Immunotherapy Market | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Germany Allergy Immunotherapy Market | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Allergopharma (DE) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Boehringer Ingelheim (DE) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Merck KGaA (DE) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Stallergenes Greer (FR) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Anergis (CH) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 ALK-Abello (DK) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Novartis (CH) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Roxall (DE) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 TheraP (DE) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 GERMANY MARKET ANALYSIS BY INDICATION |
6. 6.3 GERMANY MARKET ANALYSIS BY TYPE OF IMMUNOTHERAPY |
7. 6.4 GERMANY MARKET ANALYSIS BY ADMINISTRATION ROUTE |
8. 6.5 GERMANY MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
9. 6.6 KEY BUYING CRITERIA OF GERMANY ALLERGY IMMUNOTHERAPY MARKET |
10. 6.7 RESEARCH PROCESS OF MRFR |
11. 6.8 DRO ANALYSIS OF GERMANY ALLERGY IMMUNOTHERAPY MARKET |
12. 6.9 DRIVERS IMPACT ANALYSIS: GERMANY ALLERGY IMMUNOTHERAPY MARKET |
13. 6.10 RESTRAINTS IMPACT ANALYSIS: GERMANY ALLERGY IMMUNOTHERAPY MARKET |
14. 6.11 SUPPLY / VALUE CHAIN: GERMANY ALLERGY IMMUNOTHERAPY MARKET |
15. 6.12 GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY INDICATION, 2024 (% SHARE) |
16. 6.13 GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY INDICATION, 2024 TO 2035 (USD Million) |
17. 6.14 GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF IMMUNOTHERAPY, 2024 (% SHARE) |
18. 6.15 GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF IMMUNOTHERAPY, 2024 TO 2035 (USD Million) |
19. 6.16 GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY ADMINISTRATION ROUTE, 2024 (% SHARE) |
20. 6.17 GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY ADMINISTRATION ROUTE, 2024 TO 2035 (USD Million) |
21. 6.18 GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE) |
22. 6.19 GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Million) |
23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
24. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
25. 7.2 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY INDICATION, 2026-2035 (USD Million) | |
  2. 7.2.2 BY TYPE OF IMMUNOTHERAPY, 2026-2035 (USD Million) | |
  3. 7.2.3 BY ADMINISTRATION ROUTE, 2026-2035 (USD Million) | |
  4. 7.2.4 BY PATIENT DEMOGRAPHICS, 2026-2035 (USD Million) |
26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
27. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Germany Allergy Immunotherapy Market Segmentation

Germany Allergy Immunotherapy Market By Indication (USD Million, 2022-2035)

Allergic Rhinitis
Allergic Asthma
Atopic Dermatitis
Food Allergies

Germany Allergy Immunotherapy Market By Type of Immunotherapy (USD Million, 2022-2035)

Subcutaneous Immunotherapy
Sublingual Immunotherapy
Oral Immunotherapy
Intranasal Immunotherapy

Germany Allergy Immunotherapy Market By Administration Route (USD Million, 2022-2035)

Injection
Sublingual
Oral
Intranasal

Germany Allergy Immunotherapy Market By Patient Demographics (USD Million, 2022-2035)

Pediatric
Adult
Geriatric
Gender Specific

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓